Skip to main content
LFMD
NASDAQ Life Sciences

LifeMD Misses Q4 Revenue Estimates with $46.9M, Beats on Adjusted EBITDA

Tom Rudovsky · Reported by Reuters
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.6
Mkt Cap
$150.184M
52W Low
$2.56
52W High
$15.84
52W Position info
41% above low
Off High info
77% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

LFMD sits 41% above its 52-week low of $2.56 on elevated volume (1.9× avg).

Summary

LifeMD, Inc. reported fourth-quarter revenue of $46.9 million, falling short of the IBES estimate of $48.6 million. Despite the revenue miss, the company surpassed adjusted EBITDA expectations, posting $4.8 million compared to an estimated $4.06 million. This mixed earnings report presents a nuanced picture for investors, with top-line performance lagging but profitability exceeding forecasts. The company also issued a full-year revenue outlook of $220-230 million, which is generally in line with analyst consensus. Traders will likely focus on how the market reconciles the revenue shortfall with the stronger-than-expected profitability and forward guidance.

At the time of this announcement, LFMD was trading at $3.60 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $150.2M. The 52-week trading range was $2.56 to $15.84. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LFMD - Latest Insights

LFMD
Nov 12, 2026, 4:58 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.61
Real-time Price: $1.60 info
Change: -$0.010 (-0.62%) info
Market Cap: $77.092M info
LFMD
Nov 12, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $1.60 info
Change: +$0.110 (+7%) info
Market Cap: $77.092M info
LFMD
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.54
Real-time Price: $1.60 info
Change: +$0.0599 (+4%) info
Market Cap: $77.092M info
LFMD
Nov 09, 2026, 9:39 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $1.98
Real-time Price: $1.60 info
Change: -$0.380 (-19%) info
Market Cap: $77.092M info
LFMD
Sep 15, 2026, 10:18 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.30
Real-time Price: $1.60 info
Change: -$1.69 (-51%) info
Market Cap: $77.092M info